Sigma Investment Counselors Inc. Has $8.11 Million Stake in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Sigma Investment Counselors Inc. reduced its position in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 10.7% during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 16,366 shares of the medical equipment provider's stock after selling 1,965 shares during the period. Sigma Investment Counselors Inc.'s holdings in Intuitive Surgical were worth $8,106,000 as of its most recent SEC filing.

Other institutional investors have also made changes to their positions in the company. Atala Financial Inc purchased a new position in shares of Intuitive Surgical in the fourth quarter worth approximately $25,000. Chilton Capital Management LLC boosted its holdings in shares of Intuitive Surgical by 614.3% during the first quarter. Chilton Capital Management LLC now owns 50 shares of the medical equipment provider's stock worth $25,000 after purchasing an additional 43 shares during the period. Parvin Asset Management LLC acquired a new stake in shares of Intuitive Surgical during the fourth quarter worth approximately $26,000. Global Financial Private Client LLC boosted its holdings in shares of Intuitive Surgical by 253.3% during the first quarter. Global Financial Private Client LLC now owns 53 shares of the medical equipment provider's stock worth $26,000 after purchasing an additional 38 shares during the period. Finally, Elite Financial Inc. acquired a new stake in shares of Intuitive Surgical during the first quarter worth approximately $26,000. 83.64% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Several analysts recently commented on ISRG shares. Truist Financial decreased their price target on shares of Intuitive Surgical from $605.00 to $590.00 and set a "buy" rating for the company in a report on Wednesday, April 23rd. Royal Bank Of Canada decreased their price target on shares of Intuitive Surgical from $630.00 to $605.00 and set an "outperform" rating for the company in a report on Wednesday, April 23rd. Evercore ISI raised their price target on shares of Intuitive Surgical from $470.00 to $550.00 and gave the stock an "in-line" rating in a report on Tuesday. Citigroup reiterated a "buy" rating and issued a $650.00 target price (up from $590.00) on shares of Intuitive Surgical in a research note on Thursday, May 22nd. Finally, Barclays reduced their target price on shares of Intuitive Surgical from $684.00 to $635.00 and set an "overweight" rating for the company in a research note on Thursday, April 24th. One research analyst has rated the stock with a sell rating, four have issued a hold rating and fifteen have issued a buy rating to the company's stock. According to data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and a consensus target price of $592.59.

Insider Buying and Selling at Intuitive Surgical

In other news, EVP Robert Desantis sold 188 shares of Intuitive Surgical stock in a transaction dated Monday, April 28th. The shares were sold at an average price of $515.91, for a total transaction of $96,991.08. Following the sale, the executive vice president directly owned 5,224 shares in the company, valued at approximately $2,695,113.84. The trade was a 3.47% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Jami K. Nachtsheim sold 2,400 shares of Intuitive Surgical stock in a transaction dated Thursday, May 1st. The shares were sold at an average price of $520.00, for a total transaction of $1,248,000.00. Following the sale, the director owned 6,371 shares in the company, valued at approximately $3,312,920. This trade represents a 27.36% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 4,998 shares of company stock valued at $2,611,577 in the last 90 days. Insiders own 0.70% of the company's stock.

Intuitive Surgical Trading Down 0.4%

ISRG traded down $1.97 on Thursday, hitting $526.16. 1,060,588 shares of the stock traded hands, compared to its average volume of 1,673,043. The firm has a market capitalization of $188.59 billion, a PE ratio of 77.15, a P/E/G ratio of 5.59 and a beta of 1.64. Intuitive Surgical, Inc. has a 52 week low of $413.82 and a 52 week high of $616.00. The business has a fifty day moving average price of $538.02 and a two-hundred day moving average price of $536.87.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last announced its quarterly earnings data on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.71 by $0.10. Intuitive Surgical had a net margin of 28.41% and a return on equity of 14.43%. The company had revenue of $2.25 billion during the quarter, compared to analysts' expectations of $2.19 billion. During the same quarter in the prior year, the company posted $1.50 EPS. On average, equities research analysts forecast that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.